Taysha Gene Therapies Inc [TSHA] Revenue clocked in at $7.22 million, up 54.34% YTD: What’s Next?
Taysha Gene Therapies Inc [NASDAQ: TSHA] price surged by 2.30 percent to reach at $0.06. The one-year TSHA stock forecast points to a potential upside of 68.02. The average equity rating for TSHA stock is currently 1.09, trading closer to a bullish pattern in the